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Abstract
A case-control study to determine risk factors for clinical infection with Escherichia coli was 
conducted among nursing home residents colonized with fluoroquinolone-resistant E. coli. Among 
94 subjects, 11 (12%) developed infections with E. coli. Risk factors included the presence of a 
urinary catheter or tracheostomy, diabetes mellitus, and trimethoprim-sulfamethoxazole exposure.
Resistance to fluoroquinolone (FQ) antibiotics has increased sharply in the long-term care 
setting, and FQ-resistant Escherichia coli are now among the most common antibiotic-
resistant organisms in nursing homes.1,2 A recent study demonstrated that among nursing 
home residents colonized with FQ-susceptible E. coli, nearly 50% acquired FQ-resistant E. 
coli within 1 year.3 Given that infection due to FQ-resistant E. coli is likely preceded by 
gastrointestinal colonization, the potential morbidity and mortality due to FQ-resistant E. 
coli infections in this population is high. Therefore, we performed this case-control study to 
identify risk factors for the development of clinical E. coli infections in nursing home 
residents with FQ-resistant E. coli colonization.
METHODS
A case-control study was performed in which the primary outcome was clinical infection 
with E. coli. The initial source population included all residents from 3 major nursing homes 
in the Academic Long-Term Care Network of the University of Pennsylvania: (1) facility 
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved.
Address correspondence to Jennifer Han, MD, MSCE, Division of Infectious Diseases, Department of Medicine, Hospital of the 
University of Pennsylvania, 811 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 (jennifer.han@uphs.upenn.edu). 
Potential conflicts of interest: All authors report no conflicts of interest relevant to this article.
HHS Public Access
Author manuscript
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2016 May 01.
Published in final edited form as:













#1, a 124-bed facility; (2) facility #2, a 240-bed facility; and (3) facility #3, a 200-bed 
facility.
As described previously, nursing home residents, or their legally authorized representatives, 
were approached for informed consent during the study period from March 8, 2006, to 
October 2, 2008.3 Rectal swabs (with stool visually present on the swab) were obtained and 
submitted to the study laboratory at the Philadelphia Veterans Affairs Medical Center for 
processing. Identification of E. coli from rectal swabs was performed as previously 
described, with FQ resistance defined as a levofloxacin minimum inhibitory concentration 
(MIC) ≥8 μg/mL.3 Therefore, the source population for the present study consisted of all 
patients who were colonized with FQ-resistant E. coli.
Data on baseline demographic information, comorbidities, and receipt of antibiotics or 
corticosteroids during the study period or within 30 days prior to enrollment were collected 
from medical records using standardized forms. History of a urinary catheter, tracheostomy, 
enteral feeding tube, diarrhea, fecal incontinence, and confinement to a bed or wheelchair 
within 30 days of fecal sampling were documented. The study was approved by the 
institutional review board of the University of Pennsylvania.
Cases were defined as residents who developed a clinical E. coli infection within 1 year of 
the rectal swab, or until discharge or death. Control patients were residents who did not 
develop an infection with E. coli within the same period. Infection was determined via 
medical record review by an infectious disease–trained physician (JHH) using the modified 
McGeer Criteria.4
Descriptive statistics were conducted to characterize the overall study population. Bivariate 
analyses of potential risk factors were then performed. Categorical variables were compared 
using Fisher’s exact test and continuous variables were compared using the Wilcoxon rank-
sum test. An odds ratio (OR) and 95% confidence interval (CI) were calculated to evaluate 
the strength of each association. A two-tailed P value of <0.05 was considered significant. 
All statistical calculations were performed using commercially available software (STATA 
v13.0; StataCorp LP, College Station, Texas).
RESULTS
A total of 94 patients were colonized with FQ-resistant E. coli during the study period. The 
median age of the study population was 77 years (interquartile range [IQR], 64–85 years), 
62 (66%) were male, and 66 (70%) self-identified as non-white. The distribution of patients 
among sites was 40 (42%), 46 (49%), and 8 (9%) residents for sites 1, 2, and 3, respectively. 
The median length of stay in the nursing home prior to the rectal swab was 137 days (IQR, 
28–738 days).
A total of 11 residents (12%) developed subsequent clinical infections with E. coli within 1 
year of the rectal swab. Of these, 10 (91%) had positive urine cultures, while 1 (9%) had a 
positive blood culture. The majority of infections (n =10; 91%) were due to FQ-resistant E. 
coli; however, 1 patient had a urinary tract infection due to fluoroquinolone-susceptible E. 
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coli. The median time to development of a clinical infection was 131 days (IQR, 57–299 
days).
Results of bivariate analyses are shown in Table 1. The presence of a urinary catheter (OR, 
10.4; 95% CI, 1.85–54.9; P=.003) or tracheostomy (OR, 30.4; 95% CI, 2.00–1612; P=.005) 
significantly increased the risk of developing a clinical E. coli infection. Trimethoprim-
sulfamethoxazole (TMP-SMX) exposure within 30 days prior to enrollment, or at any time 
during the study period, was associated with development of an E. coli infection (OR, 10.7; 
95% CI, 1.90–56.3; P=.003), as was the presence of diabetes mellitus (OR, 7.80; 95% CI, 
1.45–77.2; P=.007).
DISCUSSION
In this multisite, case-control study, 12% of nursing home residents who were colonized 
with FQ-resistant E. coli developed clinical infections with E. coli during the study period. 
The majority of these were urinary tract infections, and all cases except 1 were due to FQ-
resistant E. coli. Significant risk factors for a clinical infection with E. coli included 
exposure to TMP-SMX during the study period or within 30 days prior to enrollment, the 
presence of a urinary catheter or tracheostomy, and comorbid diabetes mellitus.
A novel finding of our study was that treatment with TMP-SMX was a risk factor for 
subsequent infection with E. coli. Although a mechanism for such activity is unclear, given 
that the susceptibility rate of FQ-resistant E. coli to TMP-SMX in our population was low 
(~40%), selective pressure exerted by treatment with TMP-SMX may have predisposed 
patients to infection with FQ-resistant E. coli. This finding underscores the results of a 
recent study showing high rates of inappropriate antibiotic use in nursing homes.5 While 
further exploration is needed to elucidate the association between TMP-SMX and E. coli 
infections, it is clear that standardized antibiotic stewardship measures are urgently needed 
in the nursing home setting.
Our study underscores the need for more judicious use of indwelling urinary catheters in 
nursing home residents. Up to 10% of nursing home residents have indwelling urinary 
catheters, and numerous studies have shown that the associated burden of colonization and 
infection, particularly with antibiotic-resistant organisms, is high.6–8
In addition, our study revealed an increased risk in clinical E. coli infections in patients with 
diabetes mellitus. The infection risk burden due to diabetes may be increased in the nursing 
home setting due to high rates of underlying conditions that predispose patients with 
diabetes toward infections (eg, hyperglycemia-related impairment of immune response, 
vascular insufficiency, neurogenic bladder), as well as multimorbidity.9
This study has several potential limitations. The relatively small number of infections may 
have precluded our ability to detect certain significant associations. Misclassification bias is 
a concern in case-control studies. However, medical record review for clinical infection was 
performed prior to data collection, and cases and controls were drawn from the same nursing 
home population and were classified solely based on development of infection. Pulsed-field 
gel electrophoresis of colonizing and clinical isolates was not performed for the present 
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study; therefore, we cannot definitively conclude that the observed E. coli infections arose 
from strains colonizing the gastrointestinal tract. Finally, because the study was conducted 
in a single healthcare system, these results may not be generalizable to other institutions.
In conclusion, our study demonstrated a modest rate of development of clinical E. coli 
infections among nursing home residents colonized with FQ-resistant E. coli. Future studies 
should focus on the development and implementation of guidelines for urinary catheter 
removal and on determining optimal antibiotic management of infections in nursing home 
populations.
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TABLE 1
Bivariate Analyses of Risk Factors for Clinical Infection with E. coli in Patients with Baseline Colonization 
with Fluoroquinolone-Resistant E. coli
Variable Cases (n =11) Controls (n =83) OR (95% CI) P Value
Age, median years, no. (IQR) 68 (52–85) 76 (64–85) … .15
Female sex, no. (%) 4 (36) 28 (34) 1.12 (0.22–4.86) >.99
Length of stay prior to initial swab date, median days (IQR) 150 (28–255) 122 (27–767) … .67
Site, no. (%)
 Facility #1 38 (46) 2 (18) …
 Facility #2 38 (46) 8 (73) .15
 Facility #3 7 (8) 1 (9)
Year of sampling, no. (%)
 2006 56 (67) 8 (73) …
 2007 14 (17) 1 (9) >.99
 2008 13 (16) 2 (18)
Receipt of trimethoprim-sulfamethoxazole, no. (%)a,b 5 (45) 6 (7) 10.7 (1.90–56.3) .003
Bed-bound, no. (%) 1 (9) 9 (11) 0.82 (0.02–7.19) .67
Wheelchair bound, no. (%) 6 (5) 40 (49) 1.26 (0.29–5.65) .76
Skilled nursing needed, no. (%) 4 (36) 36 (44) 0.73 (0.15–3.15) .75
Feeding tube, no. (%) 0 (0) 11 (13) … .35
Admitted from an acute care hospital, no. (%) 7 (64) 61 (73) 0.63 (0.14–3.25) .49
Hospitalization in previous year, no. (%) 7 (70) 67 (83) 0.49 (0.96–3.31) .39
Diabetes mellitus, no. (%) 9 (82) 30 (37) 7.80 (1.45–77.2) .007
Cardiovascular disease, no. (%) 3 (27) 14 (17) 1.82 (0.27–8.84) .42
Respiratory disease, no. (%) 2 (18) 10 (12) 1.60 (0.15–0.89) .63
Chronic kidney disease, no. (%)c 1 (9) 16 (19) 0.42 (0.01–3.38) .68
Malignancy, no. (%) 2 (18) 19 (23) 0.74 (0.07–4.03) >.99
Fecal incontinence, no. (%) 8 (73) 42 (51) 2.54 (0.55–15.6) .21
Decubitus ulcer, no. (%) 2 (18) 19 (23) 0.74 (0.72–4.03) >.99
Urinary catheter, no. (%) 5 (45) 6 (7) 10.4 (1.80–54.9) .003
Central venous catheter, no. (%) 1 (9) 5 (6) 1.52 (0.29–15.7) .54
Tracheostomy, no. (%) 3 (27) 1 (1.2) 30.4 (2.00–1612) .005
NOTE. OR, odds ratio; CI, confidence interval; IQR, interquartile range.
a
<30 d prior to enrollment up to study follow-up.
b
All other antibiotic exposures had P values >.05.
c
Serum creatinine >2 mg/dL or requirement of hemodialysis.
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